This study investigated the effect of pyridostigmine administered at different levels of recovery of neuromuscular function after rocuronium during sevoflurane anaesthesia in children.
The reversal of neuromuscular block induced by nondepolarizing muscle relaxants is known to depend on several factors: depth of block at the time of administration of the antagonist 1,2 , the specific antagonist 3, 4 , the dose 4, 5 , the rate of spontaneous recovery from the muscle relaxant 6 , the concentration of inhalational anaesthetic during reversal 7 , the presence of potentiating drugs such as some antibiotics and anticonvulsants 8 , and the age of the patient 3,6,9 . Concerning the depth of block at the time of administration of the antagonist, many studies have shown that the recovery time could be shortened when the reversal agent was given when monitoring showed signs of recovery. However, the time from the muscle relaxant injection to the final recovery-that is TOF 0.7 or TOF 0.9 -was not related to the time of the administration of the reversal agents 1, 2, 6 . In these studies neostigmine or edrophonium was used as a reversal agent and there is no report with pyridostigmine, which is the choice in our institution. Our aim was to investigate whether pyridostigmine, with a slower onset and longer duration of action than both neostigmine and edrophonium 10 , shows the same reversal pattern as that previously documented for neostigmine or edrophonium in antagonizing neuromuscular block induced by rocuronium at different points during recovery from neuromuscular blockade during sevoflurane anaesthesia in children.
METHODS
After Institutional Ethics Committee approval and obtaining parents' written consent, 51 patients, ASA physical status 1 and 2, aged 3 to 10 years, and scheduled for elective surgery of at least one hour duration were included. Patients with epilepsy, neuromuscular disease, extreme body weight (out of the 5th-95th percentile range on normal growth charts), and those who had recently taken medications affecting neuromuscular transmission were excluded.
Without premedication, anaesthesia was induced with thiopentone 5-7 mg/kg and atropine 0.015 mg/kg was given intravenously. Once the patient was unconscious, the TOF-Watch ® (Organon Teknika, Boxtel, Holland) was applied, and the control value of twitch response was calibrated during mask ventilation with 8% sevoflurane. Surface electrodes were applied over the ulnar nerve on the forearm and the evoked mechanical response of the adductor pollicis muscle was measured by a piezoelectric transducer. After calibrating the TOF-Watch ® , rocuronium 0.6 mg/kg was injected over 5 seconds and the trachea was intubated when the twitch height reached 0%. Anaesthesia was maintained with 2-3% sevoflurane and 50% nitrous oxide. Neuromuscular transmission was monitored continuously. Onset time was recorded (time to twitch tension 0% from rocuronium administration) as were a number of recovery times taken from the same starting (time to twitch height 1% (T 1 ), 25% (T 25 ), 75% (T 75 ) and to a TOF ratio of 0.7 (TOF 0.7 ), 0.8 (TOF 0.8 ), 0.9 (TOF 0.9 )) as well as the recovery index (RI: time between T 25 and T 75 ).
The subjects were randomized by a computergenerated assignment to one of the four groups; a spontaneous recovery group with no reversal (group S) or to receive pyridostigmine 0.25 mg/kg with glycopyrrolate 0.01 mg/kg 5 minutes after rocuronium (group 5), at a 1% twitch height (T 1 ) (group T 1 ) or at a 25% twitch height (T 25 ) (group T 25 ).
The sample size of the current study was determined by power analysis (α=0.05, β=0.20) to reveal a significant difference in times. Power analysis indicated that 11 patients per group were required to obtain a significant difference. All data are expressed as mean (SD) or median (range). Data were compared by analysis of variance (ANOVA). The Student-Newman-Keuls test and the Tukey test were used for post hoc calculations and a value of P<0.05 was considered significant.
RESULTS
No significant differences were found between the four groups of children in terms of age, body weight, and gender (Table 1 ). There were 29 boys and 22 girls, median age (range) was 5.3 (3.0-9.9) years and body weight 21.0 (12.0-50.0) kg.
After rocuronium administration, the onset of maximal block was not significantly different between the groups with a mean value of 1.1 (0.5) min. The clinical duration (time to T 25 ) and RI of group S were 40.1 (8.8) min and 19.9 (9.8) min, respectively. Recovery of neuromuscular block to T 1 and T 25 was significantly faster in group 5 than in group S. Recovery to T 75 , TOF 0.7 , TOF 0.8 , and TOF 0.9 in the pyridostigmine groups (group 5, T 1 , T 25 ) were significantly faster than that of group S, but showed no significant difference related to the time of pyridostigmine administration. The RI of group 5 was significantly shorter than that of group S and the RI of groups T 1 , T 25 was significantly shorter again than that of group 5 ( Table 2 ). The time from pyridostigmine administration to recovery to TOF 0.7 , TOF 0.8 , and TOF 0.9 were significantly shorter in group T 1 , T 25 than that of group 5 ( Table 3, Figure1) .
DISCUSSION
Pyridostigmine accelerated recovery of neuromuscular block in all patients. The time from administration of rocuronium to TOF 0.7 or TOF 0.9 was decreased by approximately 30% in all the groups where pyridostigmine had been administered. This is comparable to the effect of neostigmine 6 . Bevan and colleagues 6 have shown that recovery from neuro- Values are median (range). Values are mean (SD). T1=twitch recovery to 1%, T25=twitch recovery to 25%, T75=twitch recovery to 75%, RI=recovery index (T25-T75), TOF0.7=train-of-four recovery to 0.7, TOF0.8=train-of-four recovery to 0.8, TOF0.9= train-of-four recovery to 0.9. *P<0.05 vs group S; †P<0.05 vs group S, 5; ‡recovery times were measured from the start of injection of rocuronium. muscular block occurs more rapidly in children than in adults and neostigmine accelerated recovery by approximately 40% in both children and adults whether administered early or late. When neostigmine was administered at T 25 , time from neostigmine administration to TOF 0.7 was about 3.2 min and RI was about 2.1 min. In our study, corresponding values were 9.3 min and 5.1 min respectively. It seems that recovery with pyridostigmine is prolonged compared to neostigmine. In Bevan's study, the rocuronium dose was 1.1 times the ED 95 dose for children during propofol anesthesia 11, 12 . In our study, the rocuronium dose was 1.5 times the ED 95 dose and the maintenance agent was sevoflurane. In addition, sevoflurane prolongs the recovery from rocuronium block by 30-50% compared to balanced anesthesia [13] [14] [15] . This was also seen as a prolonged spontaneous recovery time to T 25 with sevoflurane anesthesia (16.6 min vs 42.2 min). Both the action and the reversal of neuromuscular block are highly age-dependent. The age-related effect is related to both the administered muscle relaxant and the reversal agent. In general, the dose of a nondepolarizing agent required to produce a specific degree of relaxation is similar in neonates, infants, and adolescents (more than thirteen years) but in children from three to ten years the required dose is significantly greater 16 . Infants recover faster than young children who again recover faster than older children 3 . We limited the age range to 3-10 years and there was no significant difference in age among the four study groups, so there should not have been an age effect on reversal pattern between groups.
Three anticholinesterase drugs, neostigmine, pyridostigmine and edrophonium are used clinically to antagonize the residual neuromuscular block produced by nondepolarizing neuromuscular blockers. Neostigmine appears preferable to either edrophonium or pyridostigmine when profound (>90%) block is to be antagonized, and edrophonium is known to have the fastest onset of action among the three drugs 2, 3, 17 . Pyridostigmine is known to have slow onset and long duration of action, with fewer muscarinic side-effects than neostigmine. Though there are slight differences in the mode of action and characteristics, these three agents are all successfully used to antagonize neuromuscular blockade 18 .
The term "satisfactory" recovery of neuromuscular function, after the administration of a nondepolarizing neuromuscular blocking drug, causes some controversy. Diaphragmatic function has returned by TOF 0.25 , and maximal inspiratory and expiratory force are restored at TOF 0.7 , but ventilatory response to hypoxia and the function of the muscles of the pharynx and the upper oesophagus, which protect the airway against regurgitation and aspiration, are impaired until TOF 0.9 19 . Postoperative residual curarization has been defined as a TOF ratio <0.7, or more recently 20 as <0.8. Others have suggested that adequate recovery of neuromuscular function, especially for maintenance of the upper airway, requires the return of the TOF ratio to ≥ 0.9. We chose TOF 0.9 as the end point for our study 19 The results of this study demonstrated that the RI and the time from administration of pyridostigmine to recovery of neuromuscular block (TOF >0.9) was shortened when pyridostigmine was given when there was some evidence of recovery (at T 1 or T 25 ) compared to it being given during intense block (5 min after rocuronium administration). However, the time from administration of rocuronium to recovery of neuromuscular block was similar whether pyridostigmine was given early or late. The pattern of these results with pyridostigmine was not different from those previously described with neostigmine or edrophonium 1, 2, 6, 11, 21 . The proposed significance of this information for clinical practice has differed. Some have suggested that there is no reason to delay the administration of antagonist, as the time from administration of muscle relaxant to recovery of neuromuscular block is similar whether the antagonist is given early or late 6 . In contrast it has been argued that as the time from administration of antagonist to recovery is shortened and more predictable when antagonist is given when there is evidence of spontaneous recovery, the reversal agent should be given later, thus shortening the interval between administration of reversal and recovery 1, 2, 18, 21 .
In summary, after rocuronium-induced neuromuscular blockade during sevoflurane anaesthesia in children, the pattern of recovery of neuromuscular function produced by pyridostigmine administered at various levels of recovery was similar to that reported for neostigmine and edrophonium 1, 2, 6, 11, 21 . The time to TOF >0.9 was approximately 30% shorter in all pyridostigmine groups compared to spontaneous recovery. The total recovery time to TOF >0.9 from the time of rocuronium administration was not related to the time of pyridostigmine administration. However, the time from administration of reversal agent to recovery is shortened when pyridostigmine is administered after signs of spontaneous recovery are evident. Clinically, we prefer to make the time from administration of reversal agent to full recovery shorter and more predictable by giving pyridostigmine when there is evidence of spontaneous recovery.
